Health TrialsbyHealthPanel

A Clinical Study for Developing Artificial Intelligence(AI)-Based Clustering Model for Personalized Medicine in Acute Respiratory Failure

ConditionAcute Respiratory Failure
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSamsung Medical Center

About this trial

The investigators will prospectively collect clinical information to develop a clustering analysis model and confirm phenotype for patients with acute respiratory failure who admit to the intensive care unit and require oxygen supply beyond a high flow nasal cannula, and a control group without acute respiratory failure. and clinical characteristics and prognosis will be compared.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18 or older

Patients who do not require high flow nasal cannula (HFNC), non-invasive ventilation (NIV (BIPAP or CPAP)), or mechanical ventilation (MV) treatment

Disqualifiers

Patients 48 hours after oxygen treatment (HFNC, NIV (BIPAP or CPAP), MV)

Patients transferred from another hospital

Patients with limitations in treatment

Trial population

1. Patients with acute respiratory failure admitted to the internal medicine intensive care unit of Samsung Seoul Hospital 1) Age 18 or older 2) Patients who require treatment with high flow nasal cannula (HFNC), non-invasive ventilation (NIV (BIPAP or CPAP)), or mechanical ventilation (MV) due to acute respiratory failure. 2. The following patients (control group) admitted to the internal medicine intensive care unit of Samsung Seoul Hospital 1) Age 18 or older 2) Patients who do not require high flow nasal cannula (HFNC), non-invasive ventilation (NIV (BIPAP or CPAP)), or mechanical ventilation (MV) treatment

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

250 Participants
are grouped into 2 trial groups
Group A: Acute Respiratory Failure group
Group B: Control group

Trial outcomes

Primary outcomes

1

Hospital Mortality

clinical outcomes - Hospital Mortality

Time frame
From date of admission until the date of hospital discharge or date of death from any cause, whichever came first, assessed up to 1 year

Secondary outcomes

1

ICU Mortality

clinical outcomes - ICU Mortality

Time frame
From date of ICU admission until the date of ICU discharge or date of death from any cause, whichever came first, assessed up to 6 months
2

Hospital length of stay

clinical outcomes - Hospital length of stay

Time frame
From date of hospital admission until the date of hospital discharge, assessed up to 1 years
3

ICU length of stay

clinical outcomes - ICU length of stay

Time frame
From date of ICU admission until the date of ICU discharge, assessed up to 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Samsung Medical Center

Lead sponsor

Ministry of Science and ICT, Republic of Korea

Collaborator

Source ClinicalTrials.gov
Apply now